The study of anti-cancer drug resistance using genetically engineered mouse models for BRCA1/2-mutated breast cancer


Dr Sven Rottenberg, University of Bern

Date & Time:

Monday, 27 June 2016, 11:00

Old Road Campus Research Building, 71A, B and C, Headington OX3 7DQ
Department of Oncology
About Us
We aim to enhance clinical and basic cancer research in Oxford with the ultimate goal of increasing cancer cure rates.
In Oxford, we have a great wealth of broad-ranging expertise and a powerful network of cancer researchers.
Study With Us
Our graduate training programmes for both scientists and clinicians are internationally recognised.